Mammalian cell surface antigens; related reagents

• US 6,111,090 A
• Filed: 08/14/1997
• Issued: 08/29/2000
• Est. Priority Date: 08/16/1996
• Status: Expired due to Term

• Current Assignee: Merck Sharp & Dohme Corporation (Merck & Co., Inc.)
• Original Assignee: Schering Corporation (Merck & Co., Inc.)
• Inventors: Randall, Troy D., Gorman, Daniel M., Zlotnik, Albert
• Primary Examiner(s): Saunders, David
• Assistant Examiner(s): Tung, Mary Beth
• Application Number:
  US08/911,423
• Time in Patent Office: 1,111 Days
• Field of Search: 435/69.1, 435/91.1, 435/252.3, 435/320.1, 435/455, 435/810, 514/44, 530/350, 530/326, 536/23.5
• US Class Current: 536/23.5
• CPC Class Codes: A61K 2039/55516 Proteins; Peptides
• CPC Class Codes: A61K 38/00 Medicinal preparations containing peptides peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00
• CPC Class Codes: A61K 39/39 characterised by the immunostimulating additives, e.g. chemical adjuvants
• CPC Class Codes: A61P 37/02 Immunomodulators
• CPC Class Codes: A61P 37/04 Immunostimulants
• CPC Class Codes: C07K 14/47 from mammals
• CPC Class Codes: C07K 14/705 Receptors; Cell surface antigens; Cell surface determinants tumour specific antigens C07K14/4748
• CPC Class Codes: C07K 14/70578 NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95 NGF-receptor C07K14/71, TNF-receptor C07K14/7151
• CPC Class Codes: C07K 16/28 against receptors, cell surface antigens or cell surface determinants
• CPC Class Codes: C07K 16/2878 against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
• CPC Class Codes: C07K 2317/70 characterized by effect upon binding to a cell or to an antigen
• CPC Class Codes: C07K 2319/00 Fusion polypeptide
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 435/975 Kit

Abstract

Purified genes encoding a T cell surface antigen from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this antigen are provided. Methods of using said reagents and diagnostic kits are also provided.

Claims

1. An isolated or recombinant polynucleotide that:

a) hybridizes under stringent hybridization conditions of at least 55°

C. and less than 400 mM salt to the open reading frame of SEQ ID NO;

1 or 3; and

b) encodes a polypeptide that;

i) is expressed on activated T cells; and

ii) specifically binds a polyclonal antibody generated against 12 contiguous amino acids of SEQ ID NO;

2 or 4.

2. A recombinant expression or replicating vector comprising the isolated or recombinant polynucleotide of claim 1.

3. A cell comprising the recombinant expression or replication vector of claim 2.

4. A kit comprising

a) the isolated or recombinant polynucleotide of claim 1;

and

b) instructions for use or disposal of reagents in said kit.

5. A method of producing a polypeptide, comprising expressing the recombinant expression or replication vector of claim 2 in a host cell and isolating said polypeptide, thereby producing said polypeptide.

6. A recombinant or isolated polynucleotide of claim 1, that encodes at least 15 contiguous amino residues of SEQ ID NO:

4.

7. The isolated or recombinant polynucleotide of claim 6, that encodes at least 17 contiguous amino acid residues of SEQ ID NO:

4.

8. The isolated or recombinant polynucleotide of claim 6, which comprises:

a) at least 57 contiguous nucleotides from the mature protein coding portion of SEQ ID NO;

1 or 3 that lacks an N terminal leader sequence;

or

b) is a variant due to the degeneracy of the genetic code.

9. The isolated or recombinant polynucleotide of claim 8, wherein:

a) said contiguous nucleotides are from nucleotides 26-165 or nucleotides 191-241 of SEQ ID NO;

4.

10. The isolated or recombinant polynucleotide of claim 1, wherein said hybridization occurs over the entire open reading frame of SEQ ID NO:

1.

11. The isolated or recombinant polynucleotide of claim 1, wherein said polynucleotide is a variant due to the degeneracy of the genetic code.

12. The isolated or recombinant polynucleotide of claim 1, wherein said hybridization conditions are

a) at least 60°

C.;

b) less than 150 mM salt;

or

c) both a) and b).

13. A method of producing a polynucleotide duplex comprising contacting the isolated or recombinant polynucleotide of claim 1 with a second polynucleotide for a time sufficient to produce said duplex under stringent hybridization conditions of at least 60°

C. and less than 250 mM salt;

thereby forming said duplex.

14. The polynucleotide of claim 1, which comprises:

a) a sequence encoding a mature polypeptide of SEQ ID NO;

2 or 4, that lacks an N terminal leader sequence;

or

b) a sequence encoding an extracellular domain of SEQ ID NO;

2 or 4.

15. The polynucleotide of claim 1, which:

a) comprises a sequence encoding a mature polypeptide coding portion of SEQ ID NO;

1 or 3, that does not encode an N terminal leader sequence;

or

b) comprises a sequence encoding an intracellular domain of SEQ ID NO;

2 or 4.

16. The isolated or recombinant polynucleotide of claim 1, which:

a) is attached to a solid substrate;

or

b) is detectably labeled.

17. The isolated or recombinant polynucleotide of claim 1, in a sterile composition.

18. The isolated or recombinant polynucleotide of claim 17, that encodes at least 21 contiguous amino add residues.

19. The isolated or recombinant polynucleotide of claim 1, wherein the isolated polynucleotide, synthetically produced.

20. The isolated or recombinant polynucleotide of claim 19, that encodes at least 21 contiguous amino acid residues.

21. The isolated or recombinant polynucleotide of claim 1, that encodes an antigenic polypeptide having at least 12 contignous amino acid residues.

22. The isolated or recombinant polynucleotide of claim 21, wherein said contiguous amino acid residues number at least 21.

23. An isolated or recombinant polynucleotide encoding a polypeptide that

has a conservative amino add substitution of a mature polypeptide of SEQ ID NO:

2 or 4 that lacks an N terminal leader sequence.

24. The isolated or recombinant polynucleotide of claim 23, comprising a sequence of from SEQ ID NO:

3.

25. The isolated or recombinant polynucleotide of claim 23, comprising:

a) nucleotides 124 to 751 of SEQ ID NO;

1;

or

b) nucleotides 54 to 723 of SEQ ID NO;

3.

26. A method of producing a polynucleotide duplex comprising contacting the isolated or recombinant polynucleotide of claim 23 with a second polynucleotide for a time sufficient to produce said duplex under stringent hybridization conditions of at least 60°

C. and less than 250 mM salt;

thereby forming said duplex.

27. A recombinant expression or replicating vector comprising the isolated or recombinant polynucleotide of claim 23.

28. A cell comprising the recombinant expression or replication vector of claim 27.

29. A method of producing an antigenic polypeptide, comprising expressing the recombinant expression or replication vector of claim 27 in a host cell and isolating said antigenic polypeptide, thereby producing said antigenic polypeptide.

30. A recombinant or isolated polynucleotide that hybridizes to the open reading frame of SEQ ID NO:

1 or 3 under stringent hybridization and wash conditions of at least 55°

C., a salt concentration of less than 250 mM, and 50% formamide.

31. A recombinant expression or replicating vector comprising:

a) said polynucleotide of claim 30;

or

b) a polynucleotide sequence encoding the mature polypeptide of SEQ ID NO;

4 that lacks an N terminal leader sequence.

32. A cell comprising the recombinant expression or replication vector of claim 31.

33. A method of producing an antigenic polypeptide, comprising expressing the recombinant expression or replication vector of claim 32 in a host cell and isolating said polypeptide, thereby producing said polypeptide.

34. A method of producing a polynucleotide duplex comprising contacting said polynucleotide of claim 30 with a second polynucleotide for a time sufficient to produce said duplex under stringent hybridization conditions of at least 60°

C. and less than 250 mM salt;

thereby forming said duplex.

35. The polynucleotide of claim 30:

a) wherein said hybridization conditions are at least 70°

C.;

or

b) comprises at least 36 contiguous nucleotides of the mature coding portion of SEQ ID NO;

1 or 3 that does not encode an N terminal leader sequence.

36. The polynucleotide of claim 30 comprising

a polynucleotide sequence encoding an antigenic polypeptide of at least 20 contiguous amino acids of the mature SEQ ID NO:

4 polypeptide that lacks an N terminal leader sequence.